MedKoo Cat#: 530392 | Name: NSC-632839 hydrochloride
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

NSC 632839 is an Inhibitor of ubiquitin isopeptidase activity.

Chemical Structure

NSC-632839 hydrochloride
NSC-632839 hydrochloride
CAS#157654-67-6 (HCl)

Theoretical Analysis

MedKoo Cat#: 530392

Name: NSC-632839 hydrochloride

CAS#: 157654-67-6 (HCl)

Chemical Formula: C21H22ClNO

Exact Mass: 0.0000

Molecular Weight: 339.86

Elemental Analysis: C, 74.22; H, 6.52; Cl, 10.43; N, 4.12; O, 4.71

Price and Availability

Size Price Availability Quantity
1g USD 2,150.00 4 Weeks
2g USD 3,650.00 4 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
NSC-632839; NSC 632839; NSC632839; NSC 632839 hydrochloride
IUPAC/Chemical Name
3,5-Bis[(4-methylphenyl)methylene]-4-piperidone hydrochloride
InChi Key
ZOKZLTXPTLIWOJ-BYCVLTJGSA-N
InChi Code
InChI=1S/C21H21NO.ClH/c1-15-3-7-17(8-4-15)11-19-13-22-14-20(21(19)23)12-18-9-5-16(2)6-10-18;/h3-12,22H,13-14H2,1-2H3;1H/b19-11+,20-12+;
SMILES Code
O=C1/C(CNC/C1=C\C2=CC=C(C)C=C2)=C/C3=CC=C(C)C=C3.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
NSC632839 is a nonselective isopeptidase inhibitor, which inhibits USP2, USP7, and SENP2 with EC50s of 45±4 μM, 37±1 μM, and 9.8±1.8 μM.
In vitro activity:
To further characterize NSC 632839 against purified enzymes, this study determined its inhibitory potential against purified USP2, USP7, and SENP2 and demonstrated that NSC 632839 was not only a DUB inhibitor, but also a deSUMOylase inhibitor (Fig. 5A–C). Specifically, NSC 632839 inhibited USP2, USP7, and SENP2 with EC50 values of 45 ± 4 μM, 37 ± 1 μM, and 9.8 ± 1.8 μM, respectively. Importantly, NSC 632839 did not inhibit the reporter enzyme PLA2 over the concentration range tested (1.2–150 μM), indicating that the reported inhibition was selective for isopeptidases (Fig. 5D). Reference: Protein Sci. 2008 Jun;17(6):1035-43. https://pubmed.ncbi.nlm.nih.gov/18424514/
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
DMF 10.0 29.42
DMSO 7.7 22.75
Ethanol 0.3 0.74
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 339.86 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
Nicholson B, Leach CA, Goldenberg SJ, Francis DM, Kodrasov MP, Tian X, Shanks J, Sterner DE, Bernal A, Mattern MR, Wilkinson KD, Butt TR. Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities. Protein Sci. 2008 Jun;17(6):1035-43. doi: 10.1110/ps.083450408. Epub 2008 Apr 18. PMID: 18424514; PMCID: PMC2386736.
In vitro protocol:
Nicholson B, Leach CA, Goldenberg SJ, Francis DM, Kodrasov MP, Tian X, Shanks J, Sterner DE, Bernal A, Mattern MR, Wilkinson KD, Butt TR. Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities. Protein Sci. 2008 Jun;17(6):1035-43. doi: 10.1110/ps.083450408. Epub 2008 Apr 18. PMID: 18424514; PMCID: PMC2386736.
In vivo protocol:
TBD
1: Nicholson B, Leach CA, Goldenberg SJ, Francis DM, Kodrasov MP, Tian X, Shanks J, Sterner DE, Bernal A, Mattern MR, Wilkinson KD, Butt TR. Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities. Protein Sci. 2008 Jun;17(6):1035-43. doi: 10.1110/ps.083450408. PubMed PMID: 18424514; PubMed Central PMCID: PMC2386736. 2: Aleo E, Henderson CJ, Fontanini A, Solazzo B, Brancolini C. Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. Cancer Res. 2006 Sep 15;66(18):9235-44. PubMed PMID: 16982768.